2017
DOI: 10.6061/clinics/2017(01)07
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of clinical and laboratory markers of cardiometabolic risk in overweight and obese children and adolescents

Abstract: OBJECTIVE:This study analyzed the frequency of cardiometabolic risk markers and metabolic syndrome occurrence in overweight and obese children and adolescents.METHODS:The participants included 161 overweight (n=65) and obese (n=96) individuals aged between 5 and 19 years. Clinical markers were assessed (body mass index, body fat percentage, waist circumference, acanthosis, systolic and diastolic blood pressures, laboratory parameters [glucose, insulin, cholesterol (total and fractions) and triglyceride levels … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
1
0
2

Year Published

2017
2017
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 30 publications
1
1
0
2
Order By: Relevance
“…The percentage was comparable to that of severely children affected by obesity who were 10 years of age and over and had MetS. Fortunately, this prevalence is much lower than that reported in a school-based study by Palhares et al ( 37 ), with 13.6% of obese Brazilian children having MetS (using the same definition of MetS).…”
Section: Discussionsupporting
confidence: 47%
“…The percentage was comparable to that of severely children affected by obesity who were 10 years of age and over and had MetS. Fortunately, this prevalence is much lower than that reported in a school-based study by Palhares et al ( 37 ), with 13.6% of obese Brazilian children having MetS (using the same definition of MetS).…”
Section: Discussionsupporting
confidence: 47%
“…We used logistic regression for dichotomous outcomes, and thus calculated odds ratios (OR) for childhood pre-HTN/HTN (vs. normal BP) and childhood obesity (BMI >95 th vs. <=95 th percentile) for each distinct leptin trajectory. Although we performed separate models for each of our outcomes, we did not explicitly account for multiple testing as the correlation between leptin and cardio-metabolic risks have been well established [32][33][34][35] and there are high correlations among our early adolescence cardio-metabolic outcomes. Rather, we have focused on patterns of associations consistent within each other outcomes and were conservative about isolated significant findings.…”
Section: Discussionmentioning
confidence: 99%
“…Este estudio clasificó el grado de exceso de peso según el IMC y las tablas del CDC en sobrepeso, obesidad y obesidad extrema; aunque definieron obesidad extrema un IMC mayor al p99 y los pacientes fueron de mayor edad (10-16 años). Palhares y col. 24 compararon 65 pacientes con sobrepeso versus 96 obesos y también encuentran diferencias en la prevalencia de factores de RCV clínicos y bioquímicos, pero en algunas de ellas sin diferencias significativas como el colesterol total, HDL-C, LDL-C y glucosa basal; sin embargo, sí hubo diferencias significativas con respecto al aumento de triglicéridos, insulina basal y HOMA-IR. Reinehr y col. 25 utilizando los criterios de la OITF tampoco encuentra diferencias significativas en la prevalencia de factores de RCV (colesterol total, LDL-C y HDL-C) entre los pacientes con sobrepeso, obesos y obesos extremos; pero sí encuentra una mayor prevalencia de hipertensión a mayor grado de exceso de peso y mayor prevalencia de aumento de triglicéridos entre los obesos extremos en comparación al grupo de sobrepeso y obesidad juntos, pero éstos dos grupos tuvieron la misma prevalencia de aumento de triglicéridos (16%).…”
Section: Discussionunclassified